Growth of Mycobacterium tuberculosis biofilms containing free mycolic acids and harbouring drug‐tolerant bacteria

Abstract

Summary Successful treatment of human tuberculosis requires 6–9 months' therapy with multiple antibiotics. Incomplete clearance of tubercle bacilli frequently results in disease relapse, presumably as a result of reactivation of persistent drug‐tolerant Mycobacterium tuberculosis cells, although the nature and location of these persisters are not known. In other pathogens, antibiotic tolerance is often associated with the formation of biofilms – organized communities of surface‐attached cells – but physiologically and genetically defined M. tuberculosis biofilms have not been described. Here, we show that M. tuberculosis forms biofilms with specific environmental and genetic requirements distinct from those for planktonic growth, which contain an extracellular matrix rich in free mycolic acids, and harbour an important drug‐tolerant population that persist despite exposure to high levels of antibiotics.

Shown for reading. Its publisher allows quoting it, not republishing it.

References 44

1. 1.

   Anderson GG, Dodson KW, Hooton TM, Hultgren SJ. Intracellular bacterial communities of uropathogenic Escherichia coli in urinary tract pathogenesis. Trends Microbiol. 2004;12:424-430.

   Not in our library10.1016/j.tim.2004.07.005

2. 2.

   Balaban NQ, Merrin J, Chait R, Kowalik L, Leibler S. Bacterial persistence as a phenotypic switch. Science. 2004;305:1622-1625.

   Not in our library10.1126/science.1099390

3. 3.

   Banin E, Vasil ML, Greenberg EP. Iron and Pseudomonas aeruginosa biofilm formation. Proc Natl Acad Sci USA. 2005;102:11076-11081.

   Not in our library10.1073/pnas.0504266102

4. 4.

   Bardarov S, Kriakov J, Carriere C, Yu S, Vaamonde C, McAdam RA, et al. Conditionally replicating mycobacteriophages: a system for transposon delivery to Mycobacterium tuberculosis. Proc Natl Acad Sci USA. 1997;94:10961-10966.

   Not in our library10.1073/pnas.94.20.10961

5. 5.

   Bardarov S, Pavelka MS, Sambandamurthy V, Larsen M, Tufariello J, Chan J, et al. Specialized transduction: an efficient method for generating marked and unmarked targeted gene disruptions in Mycobacterium tuberculosis, M. bovis BCG and M. smegmatis. Microbiology. 2002;148:3007-3017.

   Not in our library10.1099/00221287-148-10-3007

6. 6.

   Besra GS, Parish T, Stoker NG. Preparations of cell wall fractions from mycobacteria. Mycobacteria Protocols. 1998;91-108.

   Not in our library

7. 7.

   Betts JC, Lukey PT, Robb LC, McAdam RA, Duncan K. Evaluation of a nutrient starvation model of Mycobacterium tuberculosis persistence by gene and protein expression profiling. Mol Microbiol. 2002;43:717-731.

   Not in our library10.1046/j.1365-2958.2002.02779.x

8. 8.

   Branda SS, Vik S, Friedman L, Kolter R. Biofilms: the matrix revisited. Trends Microbiol. 2005;13:20-26.

   Not in our library10.1016/j.tim.2004.11.006

9. 9.

   Braunstein M, Griffin TI, Kriakov JI, Friedman ST, Grindley ND, Jacobs WR. Identification of genes encoding exported Mycobacterium tuberculosis proteins using a Tn552′phoA in vitro transposition system. J Bacteriol. 2000;182:2732-2740.

   Not in our library10.1128/jb.182.10.2732-2740.2000

10. 10.

    Cole ST, Brosch R, Parkhill J, Garnier T, Churcher C, Harris D, et al. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature. 1998;393:537-544.

    Not in our library10.1038/31159

11. 11.

    Costerton JW, Stewart PS, Greenberg EP. Bacterial biofilms: a common cause of persistent infections. Science. 1999;284:1318-1322.

    Not in our library10.1126/science.284.5418.1318

12. 12.

    Darzins E, Fahr G. Cord-forming property, lethality and pathogenicity of Mycobacteria. Dis Chest. 1956;30:642-648.

    Not in our library10.1378/chest.30.6.642

13. 13.

    Deb C, Daniel J, Sirakova TD, Abomoelak B, Dubey VS, Kolattukudy PE. A novel lipase belonging to the hormone-sensitive lipase family induced under starvation to utilize stored triacylglycerol in Mycobacterium tuberculosis. J Biol Chem. 2006;281:3866-3875.

    Not in our library10.1074/jbc.m505556200

14. 14.

    Dhar N, McKinney JD. Microbial phenotypic heterogeneity and antibiotic tolerance. Curr Opin Microbiol. 2007;10:30-38.

    Not in our library10.1016/j.mib.2006.12.007

15. 15.

    Dobson G, Minnikin DE, Minnikin SM, Partlett JH, Goodfellow M, Ridell MMM. Systematic Analysis of Complex Mycobacterial Lipids. 1985.

    Not in our library

16. 16.

    Fujita Y, Naka T, McNeil MR, Yano I. Intact molecular characterization of cord factor (trehalose 6,6′-dimycolate) from nine species of mycobacteria by MALDI-TOF mass spectrometry. Microbiology. 2005;151:3403-3416.

    Not in our library10.1099/mic.0.28158-0

17. 17.

    Hall-Stoodley L, Lappin-Scott H. Biofilm formation by the rapidly growing mycobacterial species Mycobacterium fortuitum. FEMS Microbiol Lett. 1998;168:77-84.

    Not in our library10.1111/j.1574-6968.1998.tb13258.x

18. 18.

    Hall-Stoodley L, Brun OS, Polshyna G, Barker LP. Mycobacterium marinum biofilm formation reveals cording morphology. FEMS Microbiol Lett. 2006;257:43-49.

    Not in our library10.1111/j.1574-6968.2006.00143.x

19. 19.

    Hopewell PC, Pai M, Maher D, Uplekar M, Raviglione MC. International standards for tuberculosis care. Lancet Infect Dis. 2006;6:710-725.

    Not in our library10.1016/s1473-3099(06)70628-4

20. 20.

    Hu Y, Henderson B, Lund PA, Tormay P, Ahmed MT, Gurcha SS, et al. A Mycobacterium tuberculosis mutant lacking the groEL homologue cpn60.1 is viable but fails to induce an inflammatory response in animal models of infection. Infect Immun. 2008;76:1535-1546.

    Not in our library10.1128/iai.01078-07

21. 21.

    Jindani A, Dore CJ, Mitchison DA. Bactericidal and sterilizing activities of antituberculosis drugs during the first 14 days. Am J Respir Crit Care Med. 2003;167:1348-1354.

    Not in our library10.1164/rccm.200210-1125oc

22. 22.

    Lenaerts AJ, Hoff D, Aly S, Ehlers S, Andries K, Cantarero L, et al. Location of persisting mycobacteria in the Guinea pig model of tuberculosis revealed by R207910. Antimicrob Agents Chemother. 2007;51:3338-3345.

    Not in our library10.1128/aac.00276-07

23. 23.

    Lewis K. Persister cells, dormancy and infectious disease. Nat Rev Microbiol. 2007;5:48-56.

    Not in our library10.1038/nrmicro1557

24. 24.

    Marsollier L, Aubry J, Coutanceau E, Andre JP, Small PL, Milon G, et al. Colonization of the salivary glands of Naucoris cimicoides by Mycobacterium ulcerans requires host plasmatocytes and a macrolide toxin, mycolactone. Cell Microbiol. 2005;7:935-943.

    Not in our library10.1111/j.1462-5822.2005.00521.x

25. 25.
    The role of iron in Mycobacterium smegmatis biofilm formation: the exochelin siderophore is essential in limiting iron conditions for biofilm formation but not for planktonic growth · 2007

    No notice
26. 26.

    Ojha A, Anand M, Bhatt A, Kremer L, Jacobs WR, Hatfull GF. GroEL1: a dedicated chaperone involved in mycolic acid biosynthesis during biofilm formation in mycobacteria. Cell. 2005;123:861-873.

    Not in our library10.1016/j.cell.2005.09.012

27. 27.

    Parish T, Smith DA, Kendall S, Casali N, Bancroft GJ, Stoker NG. Deletion of two-component regulatory systems increases the virulence of Mycobacterium tuberculosis. Infect Immun. 2003;71:1134-1140.

    Not in our library10.1128/iai.71.3.1134-1140.2003

28. 28.

    Recht J, Kolter R. Glycopeptidolipid acetylation affects sliding motility and biofilm formation in Mycobacterium smegmatis. J Bacteriol. 2001;183:5718-5724.

    Not in our library10.1128/jb.183.19.5718-5724.2001

29. 29.

    Recht J, Martinez A, Torello S, Kolter R. Genetic analysis of sliding motility in Mycobacterium smegmatis. J Bacteriol. 2000;182:4348-4351.

    Not in our library10.1128/jb.182.15.4348-4351.2000

30. 30.

    Roberts ME, Stewart PS. Modelling protection from antimicrobial agents in biofilms through the formation of persister cells. Microbiology. 2005;151:75-80.

    Not in our library10.1099/mic.0.27385-0

31. 31.
    The Enduring Hypoxic Response of Mycobacterium tuberculosis · 2008

    No notice
32. 32.

    Sambandamurthy VK, Derrick SC, Hsu T, Chen B, Larsen MH, Jalapathy KV, et al. Mycobacterium tuberculosis DeltaRD1 DeltapanCD: a safe and limited replicating mutant strain that protects immunocompetent and immunocompromised mice against experimental tuberculosis. Vaccine. 2006;24:6309-6320.

    Not in our library10.1016/j.vaccine.2006.05.097

33. 33.

    Schulze-Robbecke R, Fischeder R. Mycobacteria in biofilms. Zentralbl Hyg Umweltmed. 1989;188:385-390.

    Not in our library

34. 34.

    Singh PK, Schaefer AL, Parsek MR, Moninger TO, Welsh MJ, Greenberg EP. Quorum-sensing signals indicate that cystic fibrosis lungs are infected with bacterial biofilms. Nature. 2000;407:762-764.

    Not in our library10.1038/35037627

35. 35.

    Sirgel FA, Fourie PB, Donald PR, Padayatchi N, Rustomjee R, Levin J, et al. The early bactericidal activities of rifampin and rifapentine in pulmonary tuberculosis. Am J Respir Crit Care Med. 2005;172:128-135.

    Not in our library10.1164/rccm.200411-1557oc

36. 36.

    Spoering AL, Lewis K. Biofilms and planktonic cells of Pseudomonas aeruginosa have similar resistance to killing by antimicrobials. J Bacteriol. 2001;183:6746-6751.

    Not in our library10.1128/jb.183.23.6746-6751.2001

37. 37.

    Vilcheze C, Wang F, Arai M, Hazbon MH, Colangeli R, Kremer L, et al. Transfer of a point mutation in Mycobacterium tuberculosis inhA resolves the target of isoniazid. Nat Med. 2006;12:1027-1029.

    Not in our library10.1038/nm1466

38. 38.

    Voskuil MI, Schnappinger D, Visconti KC, Harrell MI, Dolganov GM, Sherman DR, Schoolnik GK. Inhibition of respiration by nitric oxide induces a Mycobacterium tuberculosis dormancy program. J Exp Med. 2003;198:705-713.

    Not in our library10.1084/jem.20030205

39. 39.

    Wallis RS, Patil S, Cheon SH, Edmonds K, Phillips M, Perkins MD, et al. Drug tolerance in Mycobacterium tuberculosis. Antimicrob Agents Chemother. 1999;43:2600-2606.

    Not in our library10.1128/aac.43.11.2600

40. 40.

    Watanabe M, Ohta A, Sasaki S, Minnikin DE. Structure of a new glycolipid from the Mycobacterium avium–Mycobacterium intracellulare complex. J Bacteriol. 1999;181:2293-2297.

    Not in our library10.1128/jb.181.7.2293-2297.1999

Cited by papers we hold 13

• Pathogenicity and virulence of Mycobacterium tuberculosis · 2023
  No notice
• Phenotypic adaptation of Mycobacterium tuberculosis to host-associated stressors that induce persister formation · 2022
  Not checked
• Drug resistant tuberculosis: Implications for transmission, diagnosis, and disease management · 2022
  No notice
• Evolution of Drug-Resistant Mycobacterium tuberculosis Strains and Their Adaptation to the Human Lung Environment · 2021
  No notice
• Biofilm formation in the lung contributes to virulence and drug tolerance of Mycobacterium tuberculosis · 2021
  No notice
• The thick waxy coat of mycobacteria, a protective layer against antibiotics and the host's immune system · 2020
  No notice
• A lung-on-chip model of early Mycobacterium tuberculosis infection reveals an essential role for alveolar epithelial cells in controlling bacterial growth · 2020
  No notice
• Antibiotics versus biofilm: an emerging battleground in microbial communities · 2019
  No notice
• Advance in Research on Mycobacterium tuberculosis FabG4 and Its Inhibitor · 2018
  Not checked
• Mycobacterium abscessus Smooth and Rough Morphotypes Form Antimicrobial-Tolerant Biofilm Phenotypes but Are Killed by Acetic Acid · 2018
  No notice
• Mycobacterium Biofilms · 2018
  No notice
• Thiol reductive stress induces cellulose-anchored biofilm formation in Mycobacterium tuberculosis · 2016
  No notice
• Portrait of a Pathogen: The Mycobacterium tuberculosis Proteome In Vivo · 2010
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.